Guidelines on Design and Reporting of Glaucoma Surgical Trials from Kugler Publications. Download the complimentary PDF of the report here.
24h efficacy with the dorzolamide / timolol fixed combination compared with the brimonidine / timolol fixed combination in POAG. Both the fixed combinations significantly reduce 24h IOP in POAG. DTFC provided significantly better 24-hour efficacy. - Eye (Free Article)
Improved detection of progression occurs with increased frequency of testing, although this may be at the cost of declining specificity (higher false-positive rates). - Invest Ophthalmol Vis Sci 2006
You can send a message, a letter, an e-mail or a fax, or you can call us.Use GlaucomaNet's Contact Page
Glaucoma, affecting about 4% of the population over 40 years of age, is an asymptomatic, progressive and irreversible disease which leads to blindness unless adequate treatment is provided early on. Static measurements currently performed by...